新入荷 再入荷

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications

flash sale icon タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料(
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
新品 7225円 (税込)
数量

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications

Trivalent recombinant protein vaccine induces cross-neutralization against  XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials |  Nature CommunicationsTrivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications,Trivalent recombinant protein vaccine induces cross-neutralization against  XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials |  Nature CommunicationsTrivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications,Versatile magnetic hydrogel soft capsule microrobots for targeted delivery:  iScienceVersatile magnetic hydrogel soft capsule microrobots for targeted delivery: iScience,Enhanced simulated early 21st century Arctic sea ice loss due to CMIP6  biomass burning emissions | Science AdvancesEnhanced simulated early 21st century Arctic sea ice loss due to CMIP6 biomass burning emissions | Science Advances,Child Nutrition Trends Over the Past Two Decades and Challenges for  Achieving Nutrition SDGs and National Targets in ChinaChild Nutrition Trends Over the Past Two Decades and Challenges for Achieving Nutrition SDGs and National Targets in China

 

商品情報の訂正

このページに記載された商品情報に記載漏れや誤りなどお気づきの点がある場合は、下記訂正依頼フォームよりお願い致します。

訂正依頼フォーム

商品レビュー

レビューの投稿にはサインインが必要です